"Welcome to Banner – University Medical Center South, formerly University of Arizona Medical Center – South Campus, is an academic medical center focused on providing exceptional patient care, teaching future health care professionals and conducting groundbreaking research to help the people of Arizona and beyond."

During the past decade, University of Arizona Medical Center South Campus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona Medical Center South Campus" #1 sponsor was "University of Arizona" with 5 trials, followed by "University of Virginia" with 2 trials sponsored, "Mallinckrodt" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "University of Miami" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona Medical Center South Campus" #1 collaborator was "Medical University of South Carolina" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Neurological Emergencies Treatment Trials Network (NETT)" with 2 trials as a collaborator, "Children's National Research Institute" with 1 trials as a collaborator and "MaineHealth" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona Medical Center South Campus" are "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Benzodiazepine Refractory Status Epilepticus" (1 trials), "Bipolar Disorder" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "University of Arizona Medical Center South Campus" in a lesser frequency.

Most popular intervention types in "University of Arizona Medical Center South Campus" are "Drug" (6 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Albumin" (1 trials), "CR + DCS (D-cycloserine)" (1 trials), "CR + placebo" (1 trials) and "Early Angiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona Medical Center South Campus" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Arizona Medical Center South Campus". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Arizona Medical Center South Campus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona Medical Center South Campus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".